Steris (STE) Non Operating Income (2018 - 2026)
Steris (STE) posted Non Operating Income of -$12.3 million for Q2 2026, little changed on a QoQ basis from -$12.3 million in Q1 2026, and up 12.77% year-over-year from -$10.9 million in Q2 2025.
Analysis
Steris (STE) Non Operating Income (2018 - 2026) Analysis & Trends
Steris has reported Non Operating Income for 9 years, with the latest figure at -$12.3 million in Q2 2026.
- On a quarterly basis, Non Operating Income rose 12.77% year-over-year to -$12.3 million in Q2 2026; TTM through Jun 2026 was -$52.6 million, a 29.11% increase from a year earlier, with the FY2026 full-year figure at -$54.4 million, up 22.73% from the prior year.
- Non Operating Income was -$12.3 million for Q2 2026 at Steris, roughly flat from -$12.3 million in the prior quarter.
- The five-year high for Non Operating Income was -$10.3 million in Q2 2024, with the low at -$36.9 million in Q4 2023.
- Average Non Operating Income over 5 years is -$22.3 million, with a median of -$21.9 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Non Operating Income slumped 137.18% in 2022, then surged 66.75% in 2024.
- Over 5 years, Non Operating Income stood at -$30.5 million in 2022, then retreated by 21.02% to -$36.9 million in 2023, then soared by 55.25% to -$16.5 million in 2024, then gained by 7.27% to -$15.3 million in 2025, then increased by 19.61% to -$12.3 million in 2026.
- The last three Non Operating Income figures came in at -$12.3 million (Q2 2026), -$12.3 million (Q1 2026), and -$15.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.43 Bn | 177.83 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.55 Bn | 119.33 Bn | 1.96 Bn | 82.70 Mn |
| 3 | Medtronic | 117.91 Bn | 109.10 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.51 Bn | 102.03 Bn | 4.50 Bn | 46.00 Mn |
| 5 | Boston Scientific | 66.23 Bn | 65.69 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.46 Bn | 45.21 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 33.87 Bn | 32.41 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.08 Bn | 30.13 Bn | 830.00 Mn | - |
| 9 | Steris | 21.05 Bn | 20.56 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.30 Mn |
| Mar 31, 2026 | -12.30 Mn |
| Dec 31, 2025 | -15.30 Mn |
| Sep 30, 2025 | -12.70 Mn |
| Jun 30, 2025 | -14.10 Mn |
| Mar 31, 2025 | -18.80 Mn |
| Dec 31, 2024 | -16.50 Mn |
| Sep 30, 2024 | -24.80 Mn |
| Jun 30, 2024 | -10.30 Mn |
| Mar 31, 2024 | -29.75 Mn |
| Dec 31, 2023 | -36.87 Mn |
| Sep 30, 2023 | -35.70 Mn |
| Jun 30, 2023 | -30.98 Mn |
| Mar 31, 2023 | -30.28 Mn |
| Dec 31, 2022 | -30.47 Mn |
| Sep 30, 2022 | -26.65 Mn |
| Jun 30, 2022 | -23.44 Mn |
| Mar 31, 2022 | -20.29 Mn |
| Dec 31, 2021 | -20.52 Mn |
| Sep 30, 2021 | -26.90 Mn |